The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors

INTERNATIONAL JOURNAL OF CARDIOLOGY

卷:228

Article

van der Ende, M. Yldau¹  Hartman, Minke H. T.¹  Hagemeijer, Yanick¹  Meems, Laura M. G.¹  de Vries, Hendrik Sierd²  Stolk, Ronald P.²  de Boer, Rudolf A.¹  Sijtsma, Anna²  van der Meer, Peter¹  Rienstra, Michiel¹  van der Harst, Pim¹ 

[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Hanzepl 1, NL-9700 RB Groningen, Netherlands

[2] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, Groningen, Netherlands

关键词: Cardiovascular disease;    Risk factors;    LifeLines;    Prospective study;    Epidemiology;   

DOI  :  10.1016/j.ijcard.2016.11.061

来源: Elsevier

【 摘 要 】

Background: The LifeLines Cohort Study is a large three-generation prospective study and Biobank. Recruitment and data collection started in 2006 and follow-up is planned for 30 years. The central aim of LifeLines is to understand healthy ageing in the 21st century. Here, the study design, methods, baseline and major cardiovascular phenotypes of the LifeLines Cohort Study are presented. Methods and results: Baseline cardiovascular phenotypeswere defined in 9700 juvenile (8-18 years) and 152,180 adult (>= 18 years) participants. Cardiovascular disease (CVD) was defined using ICD-10 criteria. At least one cardiovascular risk factor was present in 73% of the adult participants. The prevalence, adjusted for the Dutch population, was determined for risk factors (hypertension (33%), hypercholesterolemia (19%), diabetes (4%), overweight (56%), and current smoking (19%)) and CVD (myocardial infarction (1.8%), heart failure (1.0%), and atrial fibrillation (1.3%)). Overall CVD prevalence increased with age from 9% in participants < 65 years to 28% in participants >= 65 years. Of the participantswith hypertension, hypercholesterolemia and diabetes, respectively 75%, 96% and 41% did not receive preventive pharmacotherapy. Conclusions: The contemporary LifeLines Cohort Study provides researchers with unique and novel opportunities to study environmental, phenotypic, and genetic risk factors for CVD and is expected to improve our knowledge on healthy ageing. In this contemporary Western cohortwe identified a remarkable high percentage of untreated CVD risk factors suggesting that not all opportunities to reduce the CVD burden are utilised. (C) 2016 The Authors. Published by Elsevier Ireland Ltd.

【 授权许可】

Free